Press releases

5 Mar 2018

Pharmaceutical companies and non-profits team up to provide affordable hepatitis C treatment in Latin America

Press releases

6 Feb 2018

New open source drug discovery project aims to develop mycetoma treatment

Press releases

31 Jan 2018

Sanofi, DNDi seek European Medicines Agency review for sleeping sickness treatment

Press releases

13 Nov 2017

Pharmaniaga, Pharco and DNDi sign agreement to provide affordable hepatitis C treatment in Malaysia

Press releases

8 Nov 2017

DNDi/GARDP opens new South Africa liaison office, hosted by South African Medical Research Council

Press releases

4 Nov 2017

Phase II/III studies show high efficacy and safety of fexinidazole, the first oral treatment for sleeping sickness

Press releases

20 Sep 2017

DNDi welcomes Malaysia’s move to secure access to more affordable treatments for hepatitis C

Press releases

4 Sep 2017

More than EUR 56 million raised to fund initiative to fight antibiotic resistance

Press releases

31 Aug 2017

U.S. FDA approves Chemo Group’s benznidazole to treat children with Chagas disease

Press releases

8 Aug 2017

DNDi welcomes Dr Marie-Paule Kieny as new Chair of the Board of Directors with Prof. Marcel Tanner stepping down after ten successful years

Press releases

7 Jul 2017

Antibiotic-resistant gonorrhoea on the rise; need for new drugs

Press releases

6 Jul 2017

Entasis Therapeutics and the Global Antibiotic Research & Development Partnership (GARDP) to develop a new treatment for drug-resistant gonorrhea

Press releases

19 Jun 2017

Clinical trial for a better treatment for mycetoma starts in Sudan

Press releases

6 Jun 2017

Child-friendly formulation of WHO-recommended HIV treatment now approved by the CDSCO

Press releases

3 May 2017

New open source project engages universities in neglected diseases drug discovery

Press releases

19 Apr 2017

Merck joins DNDi’s ‘Drug Discovery Booster’ to accelerate discovery of new treatments for neglected diseases